Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Research

Randomly controlled drivers using minimally invasive sampling: assessment of drug prevalence in Western Switzerland over two time periods

Authors: Timothée Joye, Julien Déglon, Nicolas Donzé, Federica Gilardi, Jonathan Sidibé, Bernard Favrat, Marc Augsburger, Aurélien Thomas

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

According to the World Health Organization, road traffic injuries lead to 1.3 million deaths each year and represent the leading cause of death for young adults under 30 years old. The use of psychoactive substances, including alcohol, drugs and pharmaceuticals, is a well-known risk factor for road traffic injuries. Our study aims to assess the prevalence of substances consumed by drivers in western Switzerland. Such studies are pivotal to improving prevention and developing public awareness campaigns.

Methods

To assess the prevalence of psychoactive substances among drivers, roadside controls were performed in collaboration with local police, using their classical sampling procedures to detect drivers under the influence of drugs or alcohol over two time periods (P1: 2006-2008, P2: 2017-2020). When impaired driving was not suspected by the police, minimally invasive sampling strategies (i.e., oral fluids during P1 and dried blood spots during P2) were performed on volunteer drivers after a road safety survey. A posteriori analyses and statistical interpretation were then performed.

Results

Among the 1605 drivers included in the study, 1048 volunteers provided an oral fluid sample, while 299 provided a dried blood spot sample. The percentage of drivers testing positive for at least one substance that can impact driving abilities was stable over time, with a rate of 10.5% positivity measured over both periods. Considering the different categories of substances, a slight variation was observed between both periods, with 7.6 and 6.3% of pharmaceuticals and 3.6 and 4.9% of illicit drugs for P1 and P2, respectively. Regarding the consumption of illicit drugs, the highest percentage of positivity was measured in biological fluids of drivers under the age of 35, during nights and week-ends, periods which are considered particularly prone to fatal accidents for this age group. Disturbingly, the road safety survey highlighted that drivers’ perception of the risk of getting positively controlled while driving after drug consumption is low (3.3 on a 1-to-10 scale, N = 299).

Conclusion

The number of positive cases measured in voluntary drivers who passed the preliminary police check demonstrates the importance of systematic biofluid sampling strategies regarding driving under the influence of psychoactive substances. Although the number of fatal road accidents globally has decreased over time, the results of this study reveal the need for both better prevention and deterrent processes that could potentially reduce the risk of fatal road accidents associated with drug consumption.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (Geneva), Global status report on road safety. 2018. World Health Organization (Geneva), Global status report on road safety. 2018.
2.
go back to reference Elliott S, Woolacott H, Braithwaite R. The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims. Sci Justice. 2009;49(1):19–23.CrossRef Elliott S, Woolacott H, Braithwaite R. The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims. Sci Justice. 2009;49(1):19–23.CrossRef
3.
go back to reference Favretto D, Visentin S, Stocchero G, Vogliardi S, Snenghi R, Montisci M. Driving under the influence of drugs: prevalence in road traffic accidents in Italy and considerations on per se limits legislation. Traffic Inj Prev. 2018;19(8):786–93.CrossRef Favretto D, Visentin S, Stocchero G, Vogliardi S, Snenghi R, Montisci M. Driving under the influence of drugs: prevalence in road traffic accidents in Italy and considerations on per se limits legislation. Traffic Inj Prev. 2018;19(8):786–93.CrossRef
4.
go back to reference Lipari RN, Hughes A, Bose J. Driving Under the Influence of Alcohol and Illicit Drugs. Rockville: The CBHSQ Report; 2016. p. 1–11. Lipari RN, Hughes A, Bose J. Driving Under the Influence of Alcohol and Illicit Drugs. Rockville: The CBHSQ Report; 2016. p. 1–11.
8.
go back to reference Schuler D, Roth S, Peter C. Les médicaments psychotropes en Suisse- Quantités, coûts, acheteurs et prescripteurs. Observatoire suisse de la santé (Obsan), Neuchâtel. In. 2022;1034–2201. Schuler D, Roth S, Peter C. Les médicaments psychotropes en Suisse- Quantités, coûts, acheteurs et prescripteurs. Observatoire suisse de la santé (Obsan), Neuchâtel. In. 2022;1034–2201.
9.
go back to reference Landolt S, Rosemann T, Blozik E, Brungger B, Huber CA. Benzodiazepine and Z-drug use in Switzerland: prevalence, prescription patterns and association with adverse healthcare outcomes. Neuropsychiatr Dis Treat. 2021;17:1021–34.CrossRef Landolt S, Rosemann T, Blozik E, Brungger B, Huber CA. Benzodiazepine and Z-drug use in Switzerland: prevalence, prescription patterns and association with adverse healthcare outcomes. Neuropsychiatr Dis Treat. 2021;17:1021–34.CrossRef
10.
go back to reference Berna C. Revue Médicale Suisse : Consommation d’opioïdes entre 1985 et 2015 : chiffres suisses et mise en perspective internationale. Revue Médicale Suisse. 2018;14(612):1262–6.CrossRef Berna C. Revue Médicale Suisse : Consommation d’opioïdes entre 1985 et 2015 : chiffres suisses et mise en perspective internationale. Revue Médicale Suisse. 2018;14(612):1262–6.CrossRef
11.
go back to reference Gmel G, Kuendig H, Notari L, Gmel C. Monitorage suisse des addictions: Consommation d'alcool, de tabac et de drogues illégales en Suisse en 2016. Lausanne: Addiction Suisse eds; 2017. Gmel G, Kuendig H, Notari L, Gmel C. Monitorage suisse des addictions: Consommation d'alcool, de tabac et de drogues illégales en Suisse en 2016. Lausanne: Addiction Suisse eds; 2017.
12.
go back to reference Marthaler M. Cannabis, cocaïne, ecstasy & Cie. Rapport 2022: Actualités du monde des substances psychoactives. Infodrog eds, Centrale nationale de coordination des addictions, Berne; 2022. Marthaler M. Cannabis, cocaïne, ecstasy & Cie. Rapport 2022: Actualités du monde des substances psychoactives. Infodrog eds, Centrale nationale de coordination des addictions,  Berne; 2022.
13.
go back to reference Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG. Drugs and driving. Traffic Inj Prev. 2004;5(3):241–53.CrossRef Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG. Drugs and driving. Traffic Inj Prev. 2004;5(3):241–53.CrossRef
14.
go back to reference Steuer AE, Eisenbeiss L, Kraemer T. Blood alcohol analysis alone versus comprehensive toxicological analysis - systematic investigation of missed co-ingested other drugs in suspected alcohol-impaired drivers. Forensic Sci Int. 2016;267:52–9.CrossRef Steuer AE, Eisenbeiss L, Kraemer T. Blood alcohol analysis alone versus comprehensive toxicological analysis - systematic investigation of missed co-ingested other drugs in suspected alcohol-impaired drivers. Forensic Sci Int. 2016;267:52–9.CrossRef
15.
go back to reference Senna MC, Augsburger M, Aebi B, Briellmann TA, Donze N, Dubugnon JL, et al. First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci Int. 2010;198(1-3):11–6.CrossRef Senna MC, Augsburger M, Aebi B, Briellmann TA, Donze N, Dubugnon JL, et al. First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci Int. 2010;198(1-3):11–6.CrossRef
16.
go back to reference Ravera S, Monteiro SP, de Gier JJ, van der Linden T, Gomez-Talegon T, Alvarez FJ, et al. A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol. 2012;74(6):920–31.CrossRef Ravera S, Monteiro SP, de Gier JJ, van der Linden T, Gomez-Talegon T, Alvarez FJ, et al. A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol. 2012;74(6):920–31.CrossRef
17.
go back to reference Martin JL, Gadegbeku B, Wu D, Viallon V, Laumon B. Cannabis, alcohol and fatal road accidents. PLoS One. 2017;12(11):e0187320.CrossRef Martin JL, Gadegbeku B, Wu D, Viallon V, Laumon B. Cannabis, alcohol and fatal road accidents. PLoS One. 2017;12(11):e0187320.CrossRef
18.
go back to reference Pollini RA, Waehrer G, Kelley-Baker T. Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers. J Stud Alcohol Drugs. 2017;78(6):805–13 Pollini RA, Waehrer G, Kelley-Baker T. Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers. J Stud Alcohol Drugs. 2017;78(6):805–13
19.
go back to reference Monteiro SP, van Dijk L, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey. BMC Public Health. 2012;12:59.CrossRef Monteiro SP, van Dijk L, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey. BMC Public Health. 2012;12:59.CrossRef
20.
go back to reference Raes E, Verstraete AG. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). J Anal Toxicol. 2005;29(7):632–6.CrossRef Raes E, Verstraete AG. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). J Anal Toxicol. 2005;29(7):632–6.CrossRef
21.
go back to reference Augsburger M, Rivier L. Drugs and alcohol among suspected impaired drivers in Canton de Vaud (Switzerland). Forensic Sci Int. 1997;85(2):95–104.CrossRef Augsburger M, Rivier L. Drugs and alcohol among suspected impaired drivers in Canton de Vaud (Switzerland). Forensic Sci Int. 1997;85(2):95–104.CrossRef
22.
go back to reference Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, et al. Concentration of drugs in blood of suspected impaired drivers. Forensic Sci Int. 2005;153(1):11–5.CrossRef Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, et al. Concentration of drugs in blood of suspected impaired drivers. Forensic Sci Int. 2005;153(1):11–5.CrossRef
23.
go back to reference Maurer J, Vergalito E, Prior AF, Donze N, Thomas A, Augsburger M. Suspicion of driving under the influence of alcohol or drugs: cross sectional analysis of drug prevalence in the context of the Swiss legislation. Forensic Sci Int. 2021;329:111081.CrossRef Maurer J, Vergalito E, Prior AF, Donze N, Thomas A, Augsburger M. Suspicion of driving under the influence of alcohol or drugs: cross sectional analysis of drug prevalence in the context of the Swiss legislation. Forensic Sci Int. 2021;329:111081.CrossRef
24.
go back to reference Furuhaugen H, Jamt REG, Nilsson G, Vindenes V, Gjerde H. Roadside survey of alcohol and drug use among Norwegian drivers in 2016-2017: A follow-up of the 2008-2009 survey. Traffic Inj Prev. 2018;19(6):555–62.CrossRef Furuhaugen H, Jamt REG, Nilsson G, Vindenes V, Gjerde H. Roadside survey of alcohol and drug use among Norwegian drivers in 2016-2017: A follow-up of the 2008-2009 survey. Traffic Inj Prev. 2018;19(6):555–62.CrossRef
25.
go back to reference Beirness DJ, Beasley EE. A roadside survey of alcohol and drug use among drivers in British Columbia. Traffic Inj Prev. 2010;11(3):215–21.CrossRef Beirness DJ, Beasley EE. A roadside survey of alcohol and drug use among drivers in British Columbia. Traffic Inj Prev. 2010;11(3):215–21.CrossRef
26.
go back to reference Domingo-Salvany A, Herrero MJ, Fernandez B, Perez J, Del Real P, Gonzalez-Luque JC, et al. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015. Forensic Sci Int. 2017;278:253–9.CrossRef Domingo-Salvany A, Herrero MJ, Fernandez B, Perez J, Del Real P, Gonzalez-Luque JC, et al. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015. Forensic Sci Int. 2017;278:253–9.CrossRef
27.
go back to reference Avcioglu G, Yilmaz G, Yalcin Sahiner S, Kozaci LD, Bal C, Yilmaz FM. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls. Clin Biochem. 2021;93:112–8.CrossRef Avcioglu G, Yilmaz G, Yalcin Sahiner S, Kozaci LD, Bal C, Yilmaz FM. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls. Clin Biochem. 2021;93:112–8.CrossRef
28.
go back to reference Deglon J, Versace F, Lauer E, Widmer C, Mangin P, Thomas A, et al. Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment. Bioanalysis. 2012;4(11):1337–50.CrossRef Deglon J, Versace F, Lauer E, Widmer C, Mangin P, Thomas A, et al. Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment. Bioanalysis. 2012;4(11):1337–50.CrossRef
29.
go back to reference Wagner M, Tonoli D, Varesio E, Hopfgartner G. The use of mass spectrometry to analyze dried blood spots. Mass Spectrom Rev. 2016;35(3):361–438.CrossRef Wagner M, Tonoli D, Varesio E, Hopfgartner G. The use of mass spectrometry to analyze dried blood spots. Mass Spectrom Rev. 2016;35(3):361–438.CrossRef
30.
go back to reference Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol. 1999;52(9):633–9.CrossRef Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol. 1999;52(9):633–9.CrossRef
31.
go back to reference Joye T, Sidibe J, Deglon J, Karmime A, Sporkert F, Widmer C, et al. Liquid chromatography-high resolution mass spectrometry for broad-spectrum drug screening of dried blood spot as microsampling procedure. Anal Chim Acta. 2019;1063:110–6.CrossRef Joye T, Sidibe J, Deglon J, Karmime A, Sporkert F, Widmer C, et al. Liquid chromatography-high resolution mass spectrometry for broad-spectrum drug screening of dried blood spot as microsampling procedure. Anal Chim Acta. 2019;1063:110–6.CrossRef
32.
go back to reference Office fédéral de la statistique / Office fédéral du développement territorial. Comportement de la population en matière de transports. Résultats du microre- censement mobilité et transports 2015, Neuchâtel et Berne, 2017. Office fédéral de la statistique / Office fédéral du développement territorial. Comportement de la population en matière de transports. Résultats du microre- censement mobilité et transports 2015, Neuchâtel et Berne, 2017.
33.
go back to reference Gjerde H, Christophersen AS, Normann PT, Assum T, Oiestad EL, Morland J. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Traffic Inj Prev. 2013;14(5):443–52.CrossRef Gjerde H, Christophersen AS, Normann PT, Assum T, Oiestad EL, Morland J. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Traffic Inj Prev. 2013;14(5):443–52.CrossRef
34.
go back to reference Gómez-Talegó T, Fierro I, Del Río C, Álvarez J. Classification of medicinal drugs and driving: Co-ordination and synthesis report. In: Driving under the Influence of Drugs, Alcohol and Medicines (DRUID), European Commission under the Transport RTD Programme of the 6thFramework Program, Bruxelles; 2011. p. 1–243. Gómez-Talegó T, Fierro I, Del Río C, Álvarez J. Classification of medicinal drugs and driving: Co-ordination and synthesis report. In: Driving under the Influence of Drugs, Alcohol and Medicines (DRUID), European Commission under the Transport RTD Programme of the 6thFramework Program, Bruxelles; 2011. p. 1–243.
36.
go back to reference Compton RP, Berning A. Drug and alcohol crash risk- traffic safety facts; NHTSA's office of behavioral safety research, Washington, D.C.; 2015. Compton RP, Berning A. Drug and alcohol crash risk- traffic safety facts; NHTSA's office of behavioral safety research, Washington, D.C.; 2015.
37.
go back to reference Compton RB, A. Traffic safety facts research note: drugs and alcohol crash risk. In. Edited by transportation USDo. Washington: National Highway Traffic Safety Administration; 2015. Compton RB, A. Traffic safety facts research note: drugs and alcohol crash risk. In. Edited by transportation USDo. Washington: National Highway Traffic Safety Administration; 2015.
38.
go back to reference Thomas A, Geyer H, Schanzer W, Crone C, Kellmann M, Moehring T, et al. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer. Anal Bioanal Chem. 2012;403(5):1279–89.CrossRef Thomas A, Geyer H, Schanzer W, Crone C, Kellmann M, Moehring T, et al. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer. Anal Bioanal Chem. 2012;403(5):1279–89.CrossRef
39.
go back to reference Protti M, Rudge J, Sberna AE, Gerra G, Mercolini L. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1044-1045:77–86.CrossRef Protti M, Rudge J, Sberna AE, Gerra G, Mercolini L. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1044-1045:77–86.CrossRef
40.
go back to reference Vanlaar W. Drink driving in Belgium: results from the third and improved roadside survey. Accid Anal Prev. 2005;37(3):391–7.CrossRef Vanlaar W. Drink driving in Belgium: results from the third and improved roadside survey. Accid Anal Prev. 2005;37(3):391–7.CrossRef
41.
go back to reference Vanlaar W. Less is more: the influence of traffic count on drinking and driving behaviour. Accid Anal Prev. 2008;40(3):1018–22.CrossRef Vanlaar W. Less is more: the influence of traffic count on drinking and driving behaviour. Accid Anal Prev. 2008;40(3):1018–22.CrossRef
42.
go back to reference Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004;142(2-3):75–100.CrossRef Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004;142(2-3):75–100.CrossRef
43.
go back to reference Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009;31(4):511–9.CrossRef Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009;31(4):511–9.CrossRef
44.
go back to reference Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152(2-3):149–55.CrossRef Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152(2-3):149–55.CrossRef
45.
go back to reference Gjerde H, Mordal J, Christophersen AS, Bramness JG, Morland J. Comparison of drug concentrations in blood and oral fluid collected with the intercept sampling device. J Anal Toxicol. 2010;34(4):204–9.CrossRef Gjerde H, Mordal J, Christophersen AS, Bramness JG, Morland J. Comparison of drug concentrations in blood and oral fluid collected with the intercept sampling device. J Anal Toxicol. 2010;34(4):204–9.CrossRef
46.
go back to reference Langel K, Gjerde H, Favretto D, Lillsunde P, Oiestad EL, Ferrara SD, et al. Comparison of drug concentrations between whole blood and oral fluid. Drug Test Anal. 2014;6(5):461–71. Langel K, Gjerde H, Favretto D, Lillsunde P, Oiestad EL, Ferrara SD, et al. Comparison of drug concentrations between whole blood and oral fluid. Drug Test Anal. 2014;6(5):461–71.
47.
go back to reference Bakke E, Hoiseth G, Arnestad M, Gjerde H. Detection of drugs in simultaneously collected samples of Oral fluid and blood. J Anal Toxicol. 2019;43(3):228–32.CrossRef Bakke E, Hoiseth G, Arnestad M, Gjerde H. Detection of drugs in simultaneously collected samples of Oral fluid and blood. J Anal Toxicol. 2019;43(3):228–32.CrossRef
48.
go back to reference Aps JK, Martens LC. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int. 2005;150(2-3):119–31.CrossRef Aps JK, Martens LC. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int. 2005;150(2-3):119–31.CrossRef
Metadata
Title
Randomly controlled drivers using minimally invasive sampling: assessment of drug prevalence in Western Switzerland over two time periods
Authors
Timothée Joye
Julien Déglon
Nicolas Donzé
Federica Gilardi
Jonathan Sidibé
Bernard Favrat
Marc Augsburger
Aurélien Thomas
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-14883-2

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue